Skip to main content
. 2023 May 17;11:1170025. doi: 10.3389/fped.2023.1170025

Table 6.

Ratio between duration of therapy or height (both evaluated as surrogate endpoints of efficacy) and number of side effects.

Leuprolide Triptorelin p-value
Ratio
Duration of treatment/N side effects; [median (Q1–Q3)] 563 (411–836) 730 (395–914) 0.549
Height at the end of treatment (cm)/N side effects; [median (Q1–Q3)] 103.8 (46.5−147.2) 140.2 (133.6–149.7) 0.374